http://www.clinicaltrials.gov/ct2/show/NCT01938430?term=hepatitis+and+san+francisco&rank=197
This is the next Gilead. I was told at my SF Lab recruitment will start soon.So far UCMed is on location list. QuestLabs doesn't know if they will get this one yet. Groups are Cirrhosis with moderate and advance impairment, and 5 other groupings of post transplant. Geno 1 and 4. You don't say if you have cirrhosis or not. The earlier ION-2 group I was in you could not be cirrhotic. So Gilead is now moving on to more advance HCV patients.
For all other genotype 1 trials search using "HCV genotype 1 and san francisco". There are 4 by other manufacturers.
Hector
All Bay Area trials can be from at clinicaltrials.gov.
There are 4 Gilead trials that are recruiting in SF for special sub groups of patients. All other standard Gilead trials are ongoing or completed.
* Sofosbuvir+RBV for 16 or 24 Weeks and Sofosbuvir+PEG+RBV for 12 Weeks in Subjects With Genotype 2 or 3 Chronic HCV Infection
* Sofosbuvir Plus Ribavirin in Subjects With HCV Infection and Renal Insufficiency
* Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies
( Sofosbuvir/Ledipasvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant
Hector